Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic-3′,5′-guanosine monophosphate-stimulated phosphodiesterase to reverse hypoxic pulmonary vasoconstriction in the perfused rat lung

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 752-757

  Haynes Jr , Johnson ^b   Killilea, David W ^a   Peterson, Paul D ^b   Thompson, W Joseph ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b Depts of Medicine and Physiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; 9 (2 HYDROXY 3 NONYL)ADENINE; 9-(2-HYDROXY-3-NONYL)ADENINE; ADENINE; ADENOSINE DEAMINASE; CYCLIC GMP PHOSPHODIESTERASE; DRUG DERIVATIVE; ENZYME INHIBITOR;

ANIMAL; ARTICLE; BLOOD PRESSURE; CELL HYPOXIA; DRUG ANTAGONISM; DRUG EFFECT; LUNG; MALE; PERFUSION; RAT; SPRAGUE DAWLEY RAT; VASOCONSTRICTION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; 3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ADENINE; ADENOSINE DEAMINASE; ANIMALS; BLOOD PRESSURE; CELL HYPOXIA; ENZYME INHIBITORS; LUNG; MALE; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; VASOCONSTRICTION;

EID: 0030077686     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. BEAVO, J. A., HARDMAN, J. G. AND SUTHERLAND, E. W.: Stimulation of adenosine 3′,5′-monophosphate hydrolysis by guanosine 3′,5′-monophosphate. J. Biol. Chem. 246: 3841-3846, 1971.
2. BEAVO, J. A., CONTI, M. AND HEASLIP, R. J.: Multiple cyclic nucleotide phosphodiesterases. Mol. Pharmacol. 46: 399-405, 1994.
3. BOTHELHO, L. H. P., ROTHEMEL, J. N. D., COOMBS, R. V AND JASTORFF, B.: cAMP analog antagonists of cAMP action. Methods Enzymol. 159: 159-172, 1988.
4. EUTI, E , VAN BEMMELEN, M., FISCHER, L., WALTER, U. AND JASTORFF, B.: Inhibition of cGMP-dependent protein kinase by (Rp)-guanosine 3′,5′-monophosphorothioates. FEBS 263: 47-50, 1990.
5. CORNISH-BOWDEN, A.: Inhibitors and activators. In Fundamentals of Enzyme Kinetics, pp. 73-98, Butterworths, London, 1979.
6. DUNCAN, G. S., WOLBERG, G., SCHMITGES, G. J., DEEPROSE, R. U. AND ZIMMERMAN, T. P.: Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl) adenine. Immunopharmacology 4: 79-100, 1982.
7. ERNEUX, C., COUCHIE, D., DUMONT, J. E., BARANIAK, J., STEC, W. J., GARCIA ABBAD, E., PETRIDIS, G. AND JASTORFF, B.: Specificity of cyclic GMP activation of a multi-substrate cyclic nucleotide phosphodiesterase from rat liver. Eur. J. Biochem. 115: 503-510, 1981.
8. GIEMBYCZ, M. A. AND KELLY, J. J.: Current status of cyclic nucleotide phosphodiesterase isozymes. In Methylxanthines and Phosphodiesterase Inhibitors in the Treatment of Airway Disease, ed. by J. Costello and P. Piper, pp. 27-80, The Parthenon Publishing Group, London, 1994
9. HAYNES, J , KITHAS, P. A., TAYLOR, A. E. AND STRADA, S. J.: Selective inhibition of cGMP-inhibitable cAMP phosphodiesterase decreases pulmonary vasoreactivity. Am. J. Physiol. 261: H487-H492, 1991.
10. HAYNES, J., OBIAKO, B., THOMPSON, W. J. AND DOWNEY, J.: Adenosine-induced vasodilation: receptor characterization in pulmonary circulation. Am. J. Physiol. 268: H1862-H1868, 1995a.
11. HAYNES, J., PETERSON, P., KILLILEA, D. K. AND THOMPSON, W. J.: Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA) attenuates the hypoxic pressor response (HPR) via an adenosine receptor independent, A-kinase dependent mechanism. FASEB J 9: A276, 1995b.
12. JIANG, H., SHABB, J. B. AND CORBIN, J. D.: Cross-activation: overriding cAMP/ cGMP selectivities of protein kinases in tissues. Biochem. Cell Biol. 70: 1283-1289, 1992.
13. KISHI, Y., ASHIKAGA, T. AND NUMANO, F.: Phosphodiesterases in vascular endothelial cells. In Advances in Second Messenger and Phosphoprotein Research, vol. 25, ed. by S. Strada and H. Hidaka, pp. 201-213, Raven Press, New York, 1992.
14. KOMAS, N., LUGNIER, C., ANDRIANTSITOHAINA, R , AND STOCLET, J.: Characterization of cyclic nucleotide phospodiesterases from rat mesenteric artery. Eur. J. Pharmacol Mol. Pharmacol. 208: 85-87, 1991.
15. KONDURI, G. G., WOODARD, L. L., MUKHOPADHYAY, A., AND DESHMUKH, D. R : Adenosine is a pulmonary vasodilator in newborn lambs. Am. Rev. Respir. Dis. 146: 670-676, 1992.
16. LINCOLN, T. M., CORNWELL, T AND TAYLOR, A.: Cyclic GMP-dependent protein kinase mediates the reduction of calcium by cAMP in vascular smooth muscle cells. Am. J. Physiol. 258: C399-C407, 1990.
17. LINDGREN, S., RASCON, A., ANDERSSON, K., MANGANIELLO, V. AND DEGERMAN, E.: Selective inhibition of cGMP-inhibited and cGMP-noninhibited cyclic nucleotide phosphodiesterases and relaxation of rat aorta. Biochem. Pharmacol. 42: 545-552, 1991.
18. MANFREDI, J. P. AND HOLMES, E. W.: Purine salvage pathways in myocardium. Annu. Rev. Physiol. 47: 691-705, 1985.
19. MCCORMACK, D. G., CLARKE, B. AND BARNES, P. J.: Characterization of adenosine receptors in human pulmonary arteries. Am. J. Physiol. 256: H41-H46, 1989.
20. MCMURTRY, I. F., DAVIDSON, A. B., REEVES, J. T. AND GROVER, R. T.: Inhibition of hypoxic pulmonary vasoconstriction by calcium antagonist in isolated rat lungs. Cir. Res. 38: 99-104, 1976.
21. MENTZER, R. M., RUBIO, R. AND BERNE, R. M.: Release of adenosine by hypoxic canine lung tissue and its possible role in pulmonary circulation. Am. J. Physiol 229: 1625-1631, 1975.
22. MERY, P.-F. AND FISCHMETSTER, R.: EHNA reverses the inhibitory effect of cGMP on cardiac L-type Ca current via PDE-II inhibition. FASEB J. 8: A82, 1994.
23. MUMBY, M. C., MARTINS, T. J., CHANG, M. L AND BEAVO, J. A.: Identification of cGMP-stimulated cyclic nucleotide phosphodiesterase in lung tissue with monoclonal antibodies. J. Biol. Chem. 257: 13283-13290, 1982.
24. PODZUWEIT, T., MULLER, A. AND NENNSTIEL, P.: Selective inhibition of the cGMP-stimulated cyclic nucleotide PDE from pig and human myocardium. J. Mol. Cell Cardiol. 24: 102, 1992.
25. PRIGENT, A F., FOUGIER, S., NEMOZ, G., ANKER, G., PACHECO, H., LUGNIER, C., LEBEC, A. AND STOCLET, J.C.: Comparison of cyclic nucleotide phosphodiesterase isoforms from rat heart and bovine aorta. Biochem. Pharmacol. 37: 3671-3681, 1988.
26. RABE, K. F., TENOR, H., DENT, G., SCHUDT, C., NAKASHIMA, M. AND MAGNUSSEN, H : Identification of PDE isozymes in human pulmonary artery and effects of selective PDE inhibitors. Am. J. Physiol. 266: L536-L543, 1994.
27. SAEKI, T AND SAITO, I.: Isolation of cyclic nucleotide phosphodiesterase isozymes from pig aorta. Biochem. Pharmacol. 46: 833-839, 1993.
28. SCHAEFFER, H. J. AND SCHWENDER, D F. Enzyme inhibitors. 26. Bridging hydrophobic and hydrophillic regions on adenosine deaminase with some 9-(2-hydroxy-3-alkyl)adenines. J. Med. Chem. 17: 6-8, 1974.
29. SILVER P. J., WALUS, K. AND DISALVO, J. Adenosine-mediated relaxation and activation of cyclic AMP-dependent protein kinase in coronary arterial smooth muscle. J. Pharmacol. Exp. 228: 342-347, 1984.
30. THOMPSON, W. J., TERASAKI, W. L., EPSTEIN, P. M. AND STRADA, S. J.: Assay of cyclic nucleotide phosphodiesterase and resolution of multiple molecular forms of the enzyme. Adv. Cyclic Nucl. Res. 10: 69-92, 1979.
31. TORPHY, T. J. AND CIESLINSKI, L. B.. Characterization and selective inhibition of cyclic nucleotide phosphodiesterasc isozymes in canine tracheal smooth muscle. Mol. Pharmacol. 37: 206-214, 1989.
32. WEIR, E. K. AND ARCHER, S. L.: The mechanism of acute hypoxic pulmonary vasoconstriction: The tale of two channels. FASEB J. 9: 159-294, 1995.
33. WHALIN, M. E., SCAMMELL, J. G., STRADA, S. J. AND THOMPSON, W. J.: Phosphodiesterase II, the cGMP-activatable cyclic nucleotide phosphodiesterase, regulates cyclic AMP metabolism in PC12 cells. Mol. Pharmacol. 39: 711-717, 1991.